single-molecule sequencing Pacific Biosciences Reports 3 Percent Decrease in Q4 Revenues Q4 revenues totaled $27.1 million, down from $27.9 million in Q4 of 2019 but beating the average Wall Street estimate of $25.4 million. Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary The company plans to use the new funding, which will come from the sale of convertible senior notes due 2028, to support unspecified future growth initiatives. Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform Premium Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products. Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing The firms will conduct PacBio whole-genome sequencing on epilepsy patients to generate variant profiles that can help the development of diagnostic assays. Pacific Biosciences, Children's Mercy, Microsoft Collaborate on Rare Genetic Disease Diagnostics The organizations will apply PacBio's HiFi sequencing to a rare disease cohort whose genomes have not yet yielded causal variants by other methods. Oct 8, 2020 Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy Premium Oct 2, 2020 Pacific Biosciences Upgraded to Overweight by JP Morgan Aug 12, 2020 Pacific Biosciences Prices $86.9M Public Stock Offering Aug 3, 2020 Pacific Biosciences Q2 Revenues Drop 14 Percent Aug 3, 2020 Pacific Biosciences, Asuragen Collaborate on Clinical Assays May 19, 2020 Personal Genomics Sues Pacific Biosciences in Chinese Court for Patent Infringement May 6, 2020 Pacific Biosciences Q1 Revenues Down 5 Percent Mar 18, 2020 Jury Invalidates Pacific Biosciences Patents in Lawsuit Against Oxford Nanopore Feb 11, 2020 New Algorithms Unlock Targeted Sequencing on Nanopore Platforms Premium Feb 10, 2020 Nanopore Sequencing-Based Mapping Methods Reveal Open Chromatin, Methylation Patterns Premium Feb 7, 2020 Pacific Biosciences Targets China Clinical Market to Rebound After Illumina Deal Falls Through Premium Feb 6, 2020 Pacific Biosciences Q4 Revenues Jump 43 Percent Nov 25, 2019 Oxford Nanopore Rejects Illumina's Expanded IP Offer, Suggests NovaSeq Divestiture Nov 7, 2019 Pacific Biosciences Q3 Revenues Grow 21 Percent, Miss Expectations Sep 27, 2019 Taiwanese Firm Sues Pacific Biosciences for Patent Infringement Jul 18, 2019 European Patent Office Revokes Second Pacific Biosciences Patent May 3, 2019 Pacific Biosciences Q1 Revenues Fall 15 Percent Apr 4, 2019 High-Resolution HLA Genotyping Improves Matching, Survival Rates for Stem Cell Transplantation Premium Mar 7, 2019 PacBio Shares Early-Access Customer Experiences, New Applications for Sequel II Premium Feb 12, 2019 Oxford Nanopore Prevails in US Patent Dispute With Pacific Biosciences Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.